{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,14]],"date-time":"2026-10-14T16:53:20Z","timestamp":1791996800703,"version":"4.4.0"},"reference-count":48,"publisher":"American Medical Association (AMA)","issue":"2","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JAMA Netw Open"],"abstract":"<jats:sec id=\"ab-zoi251510-4\">\n                    <jats:title>Importance<\/jats:title>\n                    <jats:p>Reproductive factors are associated with ovarian cancer risk, but their influence may differ across menopausal status and birth cohorts.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec id=\"ab-zoi251510-5\">\n                    <jats:title>Objective<\/jats:title>\n                    <jats:p>To examine the associations between reproductive factors and ovarian cancer risk stratified by menopausal status and birth cohort.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec id=\"ab-zoi251510-6\">\n                    <jats:title>Design, Setting, and Participants<\/jats:title>\n                    <jats:p>This nationwide population-based cohort study obtained data from the National Health Insurance Service (NHIS), a single-payer system covering 97% of the population in South Korea. Women aged 40 years or older who underwent NHIS health screening in 2009 and had reproductive, clinical, and other data were included and followed up until ovarian cancer diagnosis, death, or December 31, 2022. Data were analyzed in March 2025.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec id=\"ab-zoi251510-7\">\n                    <jats:title>Exposures<\/jats:title>\n                    <jats:p>Age at menarche, parity, breastfeeding duration, oral contraceptive use, age at menopause, total reproductive span, and hormone replacement therapy use.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec id=\"ab-zoi251510-8\">\n                    <jats:title>Main Outcomes and Measures<\/jats:title>\n                    <jats:p>\n                      Incident ovarian cancer identified from NHIS claims with\n                      <jats:italic toggle=\"yes\">International Statistical Classification of Diseases and Related Health Problems, Tenth Revision<\/jats:italic>\n                      codes C56, C57, and C48 and confirmed through the Rare\/Intractable Disease Registry (code V193). Cox proportional hazards regression models estimated hazard ratios (HRs) and 95% CIs.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec id=\"ab-zoi251510-9\">\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      A total of 2\u202f285\u202f774 women (932\u202f637 [40.8%] premenopausal, 1\u202f353\u202f137 [59.2%] postmenopausal; mean [SD] age, 54.9 [10.85] years) were included in the final analytic cohort. The mean (SD) follow-up duration overall was 10.7 (2.99) years, and 10\u202f729 ovarian cancer cases were identified during follow-up. Early menarche (aged \u226412 vs &amp;amp;gt;16 years) was associated with higher ovarian cancer risk in both premenopausal women (HR, 1.37; 95% CI, 1.16-1.61) and postmenopausal women (HR, 1.24; 95% CI, 1.00-1.54). Parity of 2 or more births was associated with lower risk in both groups (HR, 0.68 [95% CI, 0.58-0.79] and 0.71 [95% CI, 0.60-0.85]). Breastfeeding for 12 months or longer and oral contraceptive use for 1 year or longer were associated with lower risk in premenopausal women but not postmenopausal women (HR, 0.86 [95% CI, 0.77-0.96] and 0.75 [95% CI, 0.61-0.93]). Among postmenopausal women, later menopause (at age \u226555 years; HR, 1.36 [95% CI, 1.11-1.66]), longer reproductive span (\u226540 years; HR, 1.21 [95% CI, 1.09-1.34]), and hormone replacement therapy use for 2 to 5 years (HR, 1.20 [95% CI, 1.07-1.34]) were associated with higher risk. Parity-related risk reduction was attenuated in the 1960s birth cohort (HR, 1.07; 95% CI, 0.52-2.19;\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      for interaction\u2009=\u2009.36).\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec id=\"ab-zoi251510-10\">\n                    <jats:title>Conclusions and Relevance<\/jats:title>\n                    <jats:p>This cohort study found that reproductive factors were associated with ovarian cancer risk, with distinct patterns across menopausal status and birth cohorts. These findings highlight the need for tailored prevention strategies in aging, low-fertility populations.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1001\/jamanetworkopen.2025.56840","type":"journal-article","created":{"date-parts":[[2026,2,3]],"date-time":"2026-02-03T16:00:30Z","timestamp":1770134430000},"page":"e2556840","source":"Crossref","is-referenced-by-count":3,"title":["Reproductive Shifts and Ovarian Cancer Risk in Women Aged 40 Years or Older"],"prefix":"10.1001","volume":"9","author":[{"given":"Jin-Hwi","family":"Kim","sequence":"first","affiliation":[{"name":"Division of Gynecologic Oncology, Department of Obstetrics and Gynecology, Uijeongbu St Mary\u2019s Hospital, College of Medicine, The Catholic University of Korea, Seoul, Korea"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"In-Sun","family":"Hwang","sequence":"additional","affiliation":[{"name":"Division of Gynecologic Oncology, Department of Obstetrics and Gynecology, Uijeongbu St Mary\u2019s Hospital, College of Medicine, The Catholic University of Korea, Seoul, Korea"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Su-Jeong","family":"Lee","sequence":"additional","affiliation":[{"name":"Division of Gynecologic Oncology, Department of Obstetrics and Gynecology, Uijeongbu St Mary\u2019s Hospital, College of Medicine, The Catholic University of Korea, Seoul, Korea"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chan-Joo","family":"Kim","sequence":"additional","affiliation":[{"name":"Division of Gynecologic Oncology, Department of Obstetrics and Gynecology, Uijeongbu St Mary\u2019s Hospital, College of Medicine, The Catholic University of Korea, Seoul, Korea"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sung-Jong","family":"Lee","sequence":"additional","affiliation":[{"name":"Division of Gynecologic Oncology, Department of Obstetrics and Gynecology, Seoul St Mary\u2019s Hospital, College of Medicine, The Catholic University of Korea, Seoul, Korea"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kyungdo","family":"Han","sequence":"additional","affiliation":[{"name":"Department of Statistics and Actuarial Science, Soongsil University, Seoul, Korea"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"10","published-online":{"date-parts":[[2026,2,3]]},"reference":[{"issue":"1","key":"zoi251510r1","doi-asserted-by":"publisher","first-page":"17","DOI":"10.3322\/caac.21763","article-title":"Cancer statistics, 2023.","volume":"73","author":"Siegel","year":"2023","journal-title":"CA Cancer J Clin"},{"issue":"3","key":"zoi251510r2","doi-asserted-by":"publisher","first-page":"209","DOI":"10.3322\/caac.21660","article-title":"Global Cancer Statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries.","volume":"71","author":"Sung","year":"2021","journal-title":"CA Cancer J Clin"},{"issue":"5","key":"zoi251510r3","doi-asserted-by":"publisher","first-page":"389","DOI":"10.1038\/s41571-024-00881-3","article-title":"Global epidemiology of epithelial ovarian cancer.","volume":"21","author":"Webb","year":"2024","journal-title":"Nat Rev Clin Oncol"},{"issue":"2","key":"zoi251510r4","doi-asserted-by":"publisher","first-page":"385","DOI":"10.4143\/crt.2023.447","article-title":"Cancer statistics in Korea: incidence, mortality, survival, and prevalence in 2020.","volume":"55","author":"Kang","year":"2023","journal-title":"Cancer Res Treat"},{"issue":"7716","key":"zoi251510r5","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1016\/S0140-6736(71)92335-X","article-title":"Incessant ovulation\u2014a factor in ovarian neoplasia?","volume":"2","author":"Fathalla","year":"1971","journal-title":"Lancet"},{"issue":"3","key":"zoi251510r6","doi-asserted-by":"publisher","first-page":"433","DOI":"10.1097\/PAS.0b013e3181cf3d79","article-title":"The origin and pathogenesis of epithelial ovarian cancer: a proposed unifying theory.","volume":"34","author":"Kurman","year":"2010","journal-title":"Am J Surg Pathol"},{"issue":"9","key":"zoi251510r7","doi-asserted-by":"publisher","first-page":"783","DOI":"10.1111\/j.0001-6349.2004.00550.x","article-title":"Review of epidemiological evidence for reproductive and hormonal factors in relation to the risk of epithelial ovarian malignancies.","volume":"83","author":"Riman","year":"2004","journal-title":"Acta Obstet Gynecol Scand"},{"issue":"1","key":"zoi251510r8","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1097\/CEJ.0000000000000217","article-title":"Ovarian cancer: epidemiology and risk factors.","volume":"26","author":"La Vecchia","year":"2017","journal-title":"Eur J Cancer Prev"},{"issue":"2","key":"zoi251510r9","doi-asserted-by":"publisher","first-page":"93","DOI":"10.5114\/pm.2023.128661","article-title":"Epidemiology and risk factors for ovarian cancer.","volume":"22","author":"Ali","year":"2023","journal-title":"Prz Menopauzalny"},{"issue":"9609","key":"zoi251510r10","doi-asserted-by":"publisher","first-page":"303","DOI":"10.1016\/S0140-6736(08)60167-1","article-title":"Ovarian cancer and oral contraceptives: collaborative reanalysis of data from 45 epidemiological studies including 23,257 women with ovarian cancer and 87,303 controls.","volume":"371","author":"Beral","year":"2008","journal-title":"Lancet"},{"issue":"9","key":"zoi251510r11","doi-asserted-by":"publisher","first-page":"1436","DOI":"10.1038\/bjc.2011.371","article-title":"Oral contraceptive use and reproductive factors and risk of ovarian cancer in the European Prospective Investigation into Cancer and Nutrition.","volume":"105","author":"Tsilidis","year":"2011","journal-title":"Br J Cancer"},{"issue":"1","key":"zoi251510r12","doi-asserted-by":"publisher","first-page":"984","DOI":"10.1186\/s12885-019-6139-6","article-title":"Global patterns and trends in ovarian cancer incidence: age, period and birth cohort analysis.","volume":"19","author":"Zhang","year":"2019","journal-title":"BMC Cancer"},{"issue":"3","key":"zoi251510r13","doi-asserted-by":"publisher","first-page":"749","DOI":"10.1002\/ijc.32322","article-title":"The influence of birth cohort and calendar period on global trends in ovarian cancer incidence.","volume":"146","author":"Cabasag","year":"2020","journal-title":"Int J Cancer"},{"issue":"6","key":"zoi251510r14","doi-asserted-by":"publisher","DOI":"10.1002\/hsr2.936","article-title":"The global, regional and national epidemiology, incidence, mortality, and burden of ovarian cancer.","volume":"5","author":"Mazidimoradi","year":"2022","journal-title":"Health Sci Rep"},{"issue":"6","key":"zoi251510r15","doi-asserted-by":"publisher","DOI":"10.1001\/jamaoncol.2020.0421","article-title":"Association between breastfeeding and ovarian cancer risk.","volume":"6","author":"Babic","year":"2020","journal-title":"JAMA Oncol"},{"issue":"10017","key":"zoi251510r16","doi-asserted-by":"publisher","first-page":"475","DOI":"10.1016\/S0140-6736(15)01024-7","article-title":"Breastfeeding in the 21st century: epidemiology, mechanisms, and lifelong effect.","volume":"387","author":"Victora","year":"2016","journal-title":"Lancet"},{"issue":"9980","key":"zoi251510r17","doi-asserted-by":"publisher","first-page":"1835","DOI":"10.1016\/S0140-6736(14)61687-1","article-title":"Menopausal hormone use and ovarian cancer risk: individual participant meta-analysis of 52 epidemiological studies.","volume":"385","author":"Beral","year":"2015","journal-title":"Lancet"},{"issue":"3","key":"zoi251510r18","doi-asserted-by":"publisher","first-page":"321","DOI":"10.1001\/jama.288.3.321","article-title":"Risks and benefits of estrogen plus progestin in healthy postmenopausal women: principal results from the Women\u2019s Health Initiative randomized controlled trial.","volume":"288","author":"Rossouw","year":"2002","journal-title":"JAMA"},{"issue":"7","key":"zoi251510r20","doi-asserted-by":"publisher","first-page":"629","DOI":"10.1093\/aje\/kwg177","article-title":"Reproductive factors and epithelial ovarian cancer risk by histologic type: a multiethnic case-control study.","volume":"158","author":"Tung","year":"2003","journal-title":"Am J Epidemiol"},{"issue":"10","key":"zoi251510r22","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pmed.0040296","article-title":"The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) statement: guidelines for reporting observational studies.","volume":"4","author":"von Elm","year":"2007","journal-title":"PLoS Med"},{"issue":"1","key":"zoi251510r23","doi-asserted-by":"publisher","first-page":"239","DOI":"10.1093\/biomet\/69.1.239","article-title":"Partial residuals for the proportional hazards regression model.","volume":"69","author":"Schoenfeld","year":"1982","journal-title":"Biometrika"},{"issue":"4","key":"zoi251510r24","doi-asserted-by":"publisher","first-page":"361","DOI":"10.1038\/s41416-024-02924-z","article-title":"Reproductive factors and risk of epithelial ovarian cancer: results from the Asia Cohort Consortium.","volume":"132","author":"Merritt","year":"2025","journal-title":"Br J Cancer"},{"issue":"24","key":"zoi251510r25","doi-asserted-by":"publisher","first-page":"2888","DOI":"10.1200\/JCO.2016.66.8178","article-title":"Ovarian cancer risk factors by histologic subtype: an analysis from the Ovarian Cancer Cohort Consortium.","volume":"34","author":"Wentzensen","year":"2016","journal-title":"J Clin Oncol"},{"issue":"1","key":"zoi251510r26","doi-asserted-by":"publisher","first-page":"9","DOI":"10.20892\/j.issn.2095-3941.2016.0084","article-title":"Epidemiology of ovarian cancer: a review.","volume":"14","author":"Reid","year":"2017","journal-title":"Cancer Biol Med"},{"key":"zoi251510r27","doi-asserted-by":"publisher","first-page":"287","DOI":"10.2147\/IJWH.S197604","article-title":"Ovarian cancer in the world: epidemiology and risk factors.","volume":"11","author":"Momenimovahed","year":"2019","journal-title":"Int J Womens Health"},{"issue":"10","key":"zoi251510r28","doi-asserted-by":"publisher","first-page":"4611","DOI":"10.3390\/ijms26104611","article-title":"Ovarian cancer\u2013epidemiology, classification, pathogenesis, treatment, and estrogen receptors\u2019 molecular backgrounds.","volume":"26","author":"Smolarz","year":"2025","journal-title":"Int J Mol Sci"},{"issue":"9","key":"zoi251510r29","doi-asserted-by":"publisher","first-page":"1059","DOI":"10.1093\/aje\/kwn006","article-title":"Hormonal risk factors for ovarian cancer in premenopausal and postmenopausal women.","volume":"167","author":"Moorman","year":"2008","journal-title":"Am J Epidemiol"},{"issue":"4","key":"zoi251510r30","doi-asserted-by":"publisher","first-page":"321","DOI":"10.1093\/aje\/kwi046","article-title":"Effect of anovulation factors on pre- and postmenopausal ovarian cancer risk: revisiting the incessant ovulation hypothesis.","volume":"161","author":"Tung","year":"2005","journal-title":"Am J Epidemiol"},{"issue":"3","key":"zoi251510r31","doi-asserted-by":"publisher","first-page":"647","DOI":"10.1093\/jnci\/53.3.647","article-title":"Breast cancer in premenopausal and postmenopausal women.","volume":"53","author":"Stavraky","year":"1974","journal-title":"J Natl Cancer Inst"},{"issue":"4","key":"zoi251510r32","doi-asserted-by":"publisher","DOI":"10.1001\/jamapediatrics.2019.5881","article-title":"Worldwide secular trends in age at pubertal onset assessed by breast development among girls: a systematic review and meta-analysis.","volume":"174","author":"Eckert-Lind","year":"2020","journal-title":"JAMA Pediatr"},{"issue":"2","key":"zoi251510r33","doi-asserted-by":"publisher","first-page":"563","DOI":"10.1215\/00703370-10585316","article-title":"Later, fewer, none? recent trends in cohort fertility in South Korea.","volume":"60","author":"Hwang","year":"2023","journal-title":"Demography"},{"issue":"11","key":"zoi251510r34","doi-asserted-by":"publisher","first-page":"1767","DOI":"10.1093\/jnci\/djae164","article-title":"Ovarian cancer risk factors in relation to family history.","volume":"116","author":"Zheng","year":"2024","journal-title":"J Natl Cancer Inst"},{"issue":"3","key":"zoi251510r35","doi-asserted-by":"publisher","first-page":"820","DOI":"10.1016\/j.ygyno.2020.09.037","article-title":"Breastfeeding and the risk of epithelial ovarian cancer among women with a BRCA1 or BRCA2 mutation.","volume":"159","author":"Kotsopoulos","year":"2020","journal-title":"Gynecol Oncol"},{"issue":"6","key":"zoi251510r36","doi-asserted-by":"publisher","first-page":"580.e1","DOI":"10.1016\/j.ajog.2017.02.002","article-title":"Lifetime cancer risk and combined oral contraceptives: the Royal College of General Practitioners\u2019 Oral Contraception Study.","volume":"216","author":"Iversen","year":"2017","journal-title":"Am J Obstet Gynecol"},{"issue":"5","key":"zoi251510r37","doi-asserted-by":"publisher","first-page":"539","DOI":"10.1093\/jnci\/djad011","article-title":"Lifetime ovulatory years and risk of epithelial ovarian cancer: a multinational pooled analysis.","volume":"115","author":"Fu","year":"2023","journal-title":"J Natl Cancer Inst"},{"issue":"1","key":"zoi251510r38","doi-asserted-by":"publisher","first-page":"352","DOI":"10.1186\/s12905-025-03904-y","article-title":"Analysis of global ovarian cancer disease burden and its changing trend from 1990 to 2021.","volume":"25","author":"Gui","year":"2025","journal-title":"BMC Womens Health"},{"key":"zoi251510r40","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2025.1652347","article-title":"Long-term trends and projections of ovarian cancer burden in China (1990 to 2040): an age-period-cohort analysis based on GBD 2021 data.","volume":"15","author":"Huang","year":"2025","journal-title":"Front Oncol"},{"issue":"11","key":"zoi251510r41","doi-asserted-by":"publisher","DOI":"10.1136\/bmjopen-2022-067826","article-title":"Impact of modifiable reproductive factors on cancer incidence and mortality in Korea: a systematic review protocol.","volume":"12","author":"Kim","year":"2022","journal-title":"BMJ Open"},{"issue":"22","key":"zoi251510r42","doi-asserted-by":"publisher","first-page":"2295","DOI":"10.1001\/jama.2011.766","article-title":"Effect of screening on ovarian cancer mortality: the Prostate, Lung, Colorectal and Ovarian (PLCO) Cancer Screening randomized controlled trial.","volume":"305","author":"Buys","year":"2011","journal-title":"JAMA"},{"issue":"2","key":"zoi251510r43","doi-asserted-by":"publisher","DOI":"10.1093\/jnci\/dju410","article-title":"Ovarian cancer risk after salpingectomy: a nationwide population-based study.","volume":"107","author":"Falconer","year":"2015","journal-title":"J Natl Cancer Inst"},{"issue":"11","key":"zoi251510r44","doi-asserted-by":"publisher","first-page":"2708","DOI":"10.3390\/cancers14112708","article-title":"Risk factors for ovarian cancer: an umbrella review of the literature.","volume":"14","author":"Whelan","year":"2022","journal-title":"Cancers (Basel)"},{"issue":"3","key":"zoi251510r45","doi-asserted-by":"publisher","first-page":"799","DOI":"10.1093\/ije\/dyw253","article-title":"Data resource profile: the National Health Information Database of the National Health Insurance Service in South Korea.","volume":"46","author":"Cheol Seong","year":"2017","journal-title":"Int J Epidemiol"},{"issue":"11","key":"zoi251510r46","doi-asserted-by":"publisher","first-page":"1192","DOI":"10.1097\/DCR.0000000000000876","article-title":"Association among obesity, metabolic health, and the risk for colorectal cancer in the general population in Korea using the National Health Insurance Service-National Sample Cohort.","volume":"60","author":"Shin","year":"2017","journal-title":"Dis Colon Rectum"},{"issue":"23","key":"zoi251510r47","doi-asserted-by":"publisher","first-page":"2402","DOI":"10.1001\/jama.2017.7112","article-title":"Risks of breast, ovarian, and contralateral breast cancer for BRCA1 and BRCA2 mutation carriers.","volume":"317","author":"Kuchenbaecker","year":"2017","journal-title":"JAMA"},{"issue":"5","key":"zoi251510r48","doi-asserted-by":"publisher","first-page":"496","DOI":"10.1111\/cge.12313","article-title":"Preventing ovarian cancer through genetic testing: a population-based study.","volume":"86","author":"Finch","year":"2014","journal-title":"Clin Genet"},{"key":"zoi251510r39","volume-title":"2020 World Ovarian Cancer Atlas","author":"World Ovarian Cancer Coalition","year":"2020"},{"key":"zoi251510r19","unstructured":"Birth statistics in 2022. Korean Statistical Information Service (KOSIS). Statistics Korea. 2023. Accessed March 30, 2025. http:\/\/kosis.kr"},{"key":"zoi251510r21","unstructured":"Fertility rates (indicator). Organisation for Economic Co-operation and Development (OECD). Accessed April 10, 2025. https:\/\/www.oecd.org\/en\/data\/indicators\/fertility-rates.html?"}],"container-title":["JAMA Network Open"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/jamanetwork.com\/journals\/jamanetworkopen\/articlepdf\/2844615\/kim_2026_oi_251510_1769460402.71541.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,2,3]],"date-time":"2026-02-03T16:00:33Z","timestamp":1770134433000},"score":1,"resource":{"primary":{"URL":"https:\/\/jamanetwork.com\/journals\/jamanetworkopen\/fullarticle\/2844615"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,2,3]]},"references-count":48,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2026,2,2]]}},"URL":"https:\/\/doi.org\/10.1001\/jamanetworkopen.2025.56840","relation":{},"ISSN":["2574-3805"],"issn-type":[{"value":"2574-3805","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,2,3]]}}}